Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

Share Price is delayed by 15 minutes
Get Live Data
222.00    -5.00 (-2.20%)
Bid:
222.00
Ask:
232.00
Spread: 10.00 (4.505%)
Market Cap: £117.21m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Share Chart

Interim Management Statement

13 May 2013 07:00

RNS Number : 4884E
Microgen PLC
13 May 2013
 



microgen

www.microgen.com

 

13 May 2013

 

INTERIM MANAGEMENT STATEMENT

 

 

Microgen plc ('Microgen' or 'Group') provides its Interim Management Statement covering the period from 1 January 2013 to the date of this announcement. Microgen released its final results for the year ending 31 December 2012 on 25 February 2013.

 

There have been no significant changes since 1 January 2013 in the financial position of Microgen and its balance sheet remains strong. The Group had net cash at 30 April 2013 of £32.3 million (31 December 2012 : £32.1 million) before payment of the dividend and special dividend totalling £6.1 million, scheduled for 28 May 2013.

 

The Board remains satisfied with the financial performance of the Group with benefit continuing to be received from its conservative operational approach and annual licencing model. The Financial Systems Division has commenced delivery of a significant 5Series project with a large global bank and continues to perform satisfactorily. The Microgen Aptitude Solutions Division ("MASD") has started implementation of a major new financial services project in North America based on both Microgen Aptitude and Accounting Hub. In addition, MASD has further strengthened its intellectual property portfolio with three new patents being granted by the US Patent Office since 1 January 2013 in respect of the Microgen Aptitude technology.

 

Strategic Review

 

The Microgen Group continues to be financially very robust with a strong balance sheet and consistent profitability/cash flow. Following payment of the dividend and special dividend, through the Board's pro-active shareholder realisation programme, Microgen will have returned to shareholders 100% of the market capitalisation as at 13 October 2008 via dividends, special dividends, tender offers and share buy-backs.

 

The Microgen Aptitude technology and related applications (e.g. Microgen Accounting Hub) continue to be affirmed as being market leading. Originally targeted at the financial services sector, which remains the core of the business, Microgen Aptitude has also established a strong reputation in the digital media sector and is now developing opportunities in both the telecom and healthcare sectors.

 

The Financial Systems Division operates in more established product categories with high recurring revenues. The core business which operates within the financial services sector has been stable for a number of years and continues to provide predictable cash flows. Furthermore, the investment in the development of the 5Series Trust & Fund administration product and an increasingly active wealth management market, have resulted in a number of new customer wins during the past year as well as upgrades from the previous 4Series product version.

 

Notwithstanding these strengths and the success of the shareholder realisation programme since October 2008, Microgen is constrained as a result of being a small, independent public company. As a provider of enterprise solutions in a risk-averse market environment, the size of the group can be an inhibitor given the very large enterprise software companies with which MASD typically competes. As a result, the Board has determined this to be an appropriate time to evaluate the Group's future strategy to maximise the potential of Microgen's market-leading technology and applications and has therefore decided to undertake a strategic review of the Group.

 

Given the financial strength of Microgen, continuing with the current strategy and structure remains a viable option. Nevertheless, the strategic review will be wide-ranging and may, or may not, result in the disposal of one or both of the operating divisions. Alternatively, the Board will also consider the merits of acquisition(s) to increase the scale of the Group, including acquisition(s) which may or may not provide operating synergies with the current operating divisions. Investec Bank Plc has been appointed to assist the Board in the strategic review.

 

The Board anticipates that this process will take several months. Further announcements will be made as appropriate.

 

 

 

 

 

 

 

Contacts

Martyn Ratcliffe, Chairman 020-7496-8100

David Sherriff, Chief Executive Officer

Philip Wood, Group Finance Director

 

James Melville-Ross, FTI Consulting 020-7831-3113

Lucy Delaney, FTI Consulting

 

Rowena Murray, Investec Bank Plc 020-7597 5970

Andrew Pinder, Investec Bank Plc

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSAMMATMBABBTJ
Date   Source Headline
24th Apr 20123:51 pmRNSDirectorate Change
24th Apr 201211:14 amRNSResult of AGM
24th Apr 20127:00 amRNSInterim Management Statement
2nd Apr 201212:03 pmRNSBlocklisting Interim Review
30th Mar 20121:23 pmRNSTotal Voting Rights
26th Mar 20123:14 pmRNSDirector/PDMR Shareholding
20th Mar 20121:11 pmRNSAnnual Information Update
12th Mar 20126:21 pmRNSHolding(s) in Company
12th Mar 201212:03 pmRNSPDMR Announcement
6th Mar 20124:37 pmRNSPosting of Annual Report and Notice of AGM
27th Feb 20127:00 amRNSPreliminary Results
14th Feb 201211:16 amRNSNotice of Results
2nd Feb 201210:18 amRNSAppointment of Non-Executive Director
26th Jan 20122:23 pmRNSHolding(s) in Company
16th Jan 20121:11 pmRNSBlocklisting Interim Review
8th Dec 201112:29 pmRNSDirector Declaration
30th Nov 20111:48 pmRNSTotal Voting Rights
9th Nov 20113:33 pmRNSDirector/PDMR Shareholding
1st Nov 20117:00 amRNSInterim Management Statement and Special Dividend
31st Oct 20111:39 pmRNSHolding(s) in Company
31st Oct 20111:34 pmRNSTotal Voting Rights
12th Oct 20113:35 pmRNSApplication for Block Listing
12th Oct 20111:12 pmRNSDirector Declaration
7th Oct 20112:10 pmRNSDirector Declaration
5th Oct 201111:39 amRNSApplication for Block Listing
30th Sep 20114:13 pmRNSTotal Voting Rights
27th Sep 20115:27 pmRNSBlock Listing Return
8th Sep 20114:24 pmRNSHolding(s) in Company
7th Sep 20113:15 pmRNSDirector/PDMR Shareholding
5th Sep 20113:29 pmRNSHolding(s) in Company
5th Sep 20111:50 pmRNSHolding(s) in Company
31st Aug 20114:53 pmRNSTotal Voting Rights
31st Aug 20119:25 amRNSHolding(s) in Company
31st Aug 20118:33 amRNSDirectorship in Another PLC
31st Aug 20117:00 amRNSDirectorate Change
15th Aug 20111:21 pmRNSDirector/PDMR Shareholding
21st Jul 20117:00 amRNSInterim Results
7th Jul 20117:00 amRNSTrading Update
1st Jul 20119:00 amRNSBlocklisting Interim Review
30th Jun 20113:07 pmRNSTotal Voting Rights
24th Jun 20112:17 pmRNSHolding(s) in Company
23rd Jun 201111:45 amRNSHolding(s) in Company
21st Jun 20114:44 pmRNSHolding(s) in Company
24th May 201110:00 amRNSDirector Declaration
4th May 20119:43 amRNSHolding(s) in Company
19th Apr 20119:34 amRNSAGM Statement
19th Apr 20117:00 amRNSInterim Management Statement
31st Mar 20119:08 amRNSTotal Voting Rights
30th Mar 201112:25 pmRNSDirector/PDMR Shareholding
25th Mar 201110:10 amRNSBlock Listing Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.